JAK2 and myeloproliferative neoplasm: The PhenoAge clock was trained to predict a composite measure of mortality risk which includes several hematological variables such as white blood cell count, white blood cell differential, and several red blood cell parameters which may be abnormal in myeloproliferative neoplasm, a hematological malignancy which is strongly associated with JAK2 mutations.